China Compounding Pharmacies Market Size & Outlook
The compounding pharmacies market in China is expected to reach a projected revenue of US$ 604.1 million by 2030. A compound annual growth rate of 5.6% is expected of China compounding pharmacies market from 2024 to 2030.
Revenue, 2023 (US$M)
$411.3
Forecast, 2030 (US$M)
$604.1
CAGR, 2024 - 2030
5.6%
Report Coverage
China
China Compounding Pharmacies Market, 2018-2030 (US$M)
Global Market
Related Markets
China compounding pharmacies market highlights
- The China compounding pharmacies market generated a revenue of USD 411.3 million in 2023 and is expected to reach USD 604.1 million by 2030.
- The China market is expected to grow at a CAGR of 5.6% from 2024 to 2030.
- In terms of segment, pain management was the largest revenue generating therapeutic area in 2023.
- Nutritional Supplements is the most lucrative therapeutic area segment registering the fastest growth during the forecast period.
Compounding pharmacies market data book summary
| Market revenue in 2023 | USD 411.3 million |
| Market revenue in 2030 | USD 604.1 million |
| Growth rate | 5.6% (CAGR from 2023 to 2030) |
| Largest segment | Pain management |
| Fastest growing segment | Nutritional Supplements |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Hormone Replacement Therapy, Pain Management, Dermatology, Specialty Drugs, Nutritional Supplements, Other Therapeutic Areas |
| Key market players worldwide | Walgreens Boots Alliance Inc, Fresh Tracks Therapeutics Inc, Fagron SA, Albertsons Companies Inc Class A, Aurora Cannabis Inc, Trxade Health Inc, Specialist Pharmacy, Galenic, Apollo Hospitals Enterprise, Formul8, Fusion Apothecary |
Other key industry trends
- In terms of revenue, China accounted for 3.1% of the global compounding pharmacies market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan compounding pharmacies market is projected to lead the regional market in terms of revenue in 2030.
- Thailand is the fastest growing regional market in Asia Pacific and is projected to reach USD 95.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Compounding Pharmacies Market Scope
Compounding Pharmacies Market segmentation & scope
Compounding Pharmacies Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Walgreens Boots Alliance Inc | View profile | 331,000 | 108 Wilmot Road, Deerfield, IL, United States, 60015 | www.walgreensbootsalliance.com |
| Fresh Tracks Therapeutics Inc | View profile | 4 | 2000 Central Avenue, Suite 100, Boulder, CO, United States, 80301 | www.frtx.com |
| Fagron SA | View profile | 3,567 | Fascinatio Boulevard 350, Rotterdam, ZH, Netherlands, 3065 WB | www.fagron.com |
| Albertsons Companies Inc Class A | View profile | 285,000 | 250 Parkcenter Boulevard, Boise, ID, United States, 83706 | www.albertsonscompanies.com |
| Aurora Cannabis Inc | View profile | 1,130 | 3498 63 Avenue, Leduc, AB, Canada, T9E 0G8 | www.auroramj.com |
| Trxade Health Inc | View profile | 8 | 2420 Brunello Trace, Lutz, FL, United States, 33558 | www.trxadehealth.com |
| Specialist Pharmacy | View profile | 11-50 | Dagenham, Barking and Dagenham, United Kingdom, Europe | specialist-pharmacy.com/ |
| Galenic | View profile | - | Boulogne-billancourt, Ile-de-France, France, Europe | galenic.com |
| Apollo Hospitals Enterprise | View profile | 10001+ | Chennai, Tamil Nadu, India, Asia | www.apollohospitals.com |
| Formul8 | View profile | 11-50 | Singapore, Central Region, Singapore, Asia | formul8.com/ |
China Compounding Pharmacies Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Compounding Pharmacies Market Outlook will help companies and investors design strategic landscapes.
Pain Management was the largest segment with a revenue share of 33.11% in 2023.
Horizon Databook has segmented the China compounding pharmacies market based on hormone replacement therapy, pain management, dermatology, specialty drugs, nutritional supplements, other therapeutic areas covering the revenue growth of each sub-segment from 2018 to 2030.
- China Compounding Pharmacies Market Therapeutic Area Outlook (Revenue, USD Million , 2018-2030)
- Hormone Replacement Therapy
- Pain Management
- Dermatology
- Specialty Drugs
- Nutritional Supplements
- Other Therapeutic Areas
- China Compounding Pharmacies Market Age Cohort Outlook (Revenue, USD Million , 2018-2030)
- Pediatric
- Adult
- Geriatric
- China Compounding Pharmacies Market Compounding Type Outlook (Revenue, USD Million , 2018-2030)
- Pharmaceutical Ingredient Alteration (PIA)
- Currently Unavailable Pharmaceutical Manufacturing (CUPM)
- Pharmaceutical Dosage Alteration (PDA)
- Other Compounding Types
- China Compounding Pharmacies Market Sterility Outlook (Revenue, USD Million , 2018-2030)
- Sterile
- Non Sterile
Reasons to subscribe to Compounding Pharmacies Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Compounding Pharmacies Market Outlook databook
- Our clientele includes a mix of Compounding Pharmacies Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China Compounding Pharmacies Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into China Compounding Pharmacies Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
China Compounding Pharmacies Market, 2018-2030 (US$M)
China compounding pharmacies market statistics, by therapeutic area, 2018-2030 (US$M)
